Andilum, Baby Girl .
HRN: 21-99-02 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/23/2022
CEFTAZIDIME 1GM (VIAL)
09/23/2022
09/29/2022
IV
27mg
Q12
Neonatal Sepsis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Disseminated Systemic Infection Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes